Category: New products
-
Challenge Seeks Point-of-Care, Home Maternal Health Technologies
A crowdsourced competition offered by NIH is seeking new technologies to monitor the health and detect early problems with new babies and their mothers, at the point of care or in the home.
-
Fujitsu, Linux Foundation Partner on Open-Source A.I.
I.T. systems company Fujitsu Ltd. is providing artificial intelligence model generation and fairness assessment software as open-source projects hosted by the Linux Foundation.
-
University Start-Up Developing Inhaled Gene Therapies
A new company spun-off from a university lab consortium is advancing gene therapies delivered through the lungs to treat rare inherited respiratory diseases.
-
Small Biz Grant Supports Regenerative Alzheimer’s Treatment
A new award from National Institutes of Health funds preclinical work to prepare for a clinical trial assessing a treatment to reverse brain signaling damage in people with Alzheimer’s disease.
-
Autoimmune Neuro Disease Start-Up Raises $58M
A new company developing treatments for neurological and psychiatric diseases from aberrant immune system activity is raising $58 million in seed funds.
-
A.I. Mammogram Screening Shown to Improve Cancer Detection
Results of a clinical trial show one radiologist using software with artificial intelligence can detect more breast cancer cases in mammograms than current reviews by two radiologists.
-
Neurons from Stem Cells Produced for Overdose Therapy Tests
Researchers use stem cells to generate human neurons resembling those in the brain that control breathing during opioid reactions, for eventual chip devices to test overdose therapies.
-
Venture Firm, Cancer Center Start Antibody Biotech Company
A company formed by M.D. Anderson Cancer Center and Panacea Venture plans to develop synthetic antibodies as treatments addressing new cancer targets.
-
Trial Shows Nasal Vaccine Reduces Whooping Cough Bacteria
Results of a clinical trial show a vaccine delivered as a nasal spray protects healthy people against infection from the bacteria causing whooping cough infections.
-
Trial Begins for Multi-Neurological Disease Therapy
A clinical trial is underway testing a new type of therapy its developer says addresses damage to nerve cells associated with a number of neurological disorders.